CoChat

Symptomatic adrenal suppression among children in Canada

The DOI matches its Crossref record; 37 of the 40 references it cites were found in a registry or an index.

Abstract

Background: Adrenal suppression (AS) is an under-recognised side effect of glucocorticoid (GC) use. AS may go undetected until a physiological stress precipitates an adrenal crisis. The incidence of AS has not been established. We sought to estimate the minimum national incidence and presenting features of paediatric symptomatic AS. Methods: Through the established methodology of the Canadian Paediatric Surveillance Program, over 2500 paediatricians were surveyed monthly for 2 years (April 2010–March 2012) to report new cases of symptomatic AS. Results: Forty-six cases of symptomatic AS were confirmed. The estimated annual incidence is 0.35/100 000 children aged 0–18 years (95% CI 0.26 to 0.47). The most common presentations were growth failure (35%), non-specific symptoms (28%) or both (13%). Adrenal crisis occurred in six cases (13%). Thirty-seven children (80%) had received inhaled corticosteroid (ICS) alone or in combination with other GC forms. Many children received high but commonly prescribed doses of ICS. Conclusions: AS is responsible for significant morbidity in children, including susceptibility to adrenal crisis. The minimal estimated incidence reported is for the entire paediatric population and would be much higher in the at-risk group (ie, children treated with GCs). Close monitoring of growth and possible symptoms of AS, which may be non-specific, are important in children on all forms of GC therapy including ICS. To reduce the risk of AS, physicians must be aware of the risk of AS, revisit GC doses frequently and use the lowest effective dose.

Overview

Integrity signals

Registry

Crossref · 10.1136/archdischild-2016-311223

Cites

37 of 37 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 37 references

Research works printed but not linked: 2

  1. Bantle, 2004, The adrenal cortex, Endocrine pathophysiology, 84
  2. Miller, 2008, The adrenal cortex and its disorders. Pediatric Endocrinology, 444

Cited by

See all 43

Metadata

Authors
Goldbloom, E. B., Mokashi, A., Cummings, E. A., Abish, S., Benseler, S. M., Huynh, H. Q., Watson, W., & Ahmet, A.
Affiliations
  • University of Ottawa (CA)
  • Dalhousie University (CA)
  • Montreal Children's Hospital (CA)
  • University of Calgary (CA)
  • University of Alberta (CA)
Corresponding author
Goldbloom, Ellen B
Venue
Archives of Disease in Childhood
Publisher
BMJ
Published
2016-11-09
Volume
102
Issue
4
Pages
338.1-339
ISSN
  • 0003-9888 (ISSN-L)
  • 1468-2044
OpenAlex
W2556561149
Cited by
41
References
40
Citations by year
2026: 5 · 2025: 1 · 2024: 4 · 2023: 1 · 2022: 1 · 2021: 5 · 2020: 4 · 2019: 6 · 2018: 8 · 2017: 5 · 2016: 1
FWCI
6.68
Type
journal article
Language
en
Open access
closed
Locations
  • Archives of Disease in Childhood (publishedVersion)
  • PubMed (publishedVersion)
  • HighWire Press Open Archive (submittedVersion)
Funders
Physicians' Services Incorporated Foundation (11-07)
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
  • Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Toxicology › Pharmacovigilance and Adverse Drug Reactions
Keywords
adrenal suppression, glucocorticoid adverse effects, inhaled corticosteroids, adrenal crisis, pediatric patients, incidence estimation, growth failure, Canadian Paediatric Surveillance Program
MeSH terms
Administration, Inhalation, Adolescent, Adrenal Insufficiency, Canada, Child, Child, Preschool, Female, Glucocorticoids, Humans, Hydrocortisone, Infant, Male, Prospective Studies

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Symptomatic adrenal suppression among children in Canada. https://app.cochat.ai/papers/10.1136/archdischild-2016-311223
The paper
Goldbloom, E. B., Mokashi, A., Cummings, E. A., Abish, S., Benseler, S. M., Huynh, H. Q., Watson, W., & Ahmet, A. (2017). Symptomatic adrenal suppression among children in Canada. Archives of Disease in Childhood. https://doi.org/10.1136/archdischild-2016-311223

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.